Embrex®Inovoject®m is a semi-automated in ovo vaccination system from Pfizer Animal Health Global Poultry designed for those hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Embrex Inovoject.

The new device allows hatcheries to benefit from the improved accuracy, reliability and efficiency of in ovo vaccination, but in a more compact form. According to Melinda Freson, Senior Manager, BioDevice Marketing, Pfizer Animal Health Global Poultry, the new device will include the same core features of the larger Inovoject in a more condensed package.

Embrex Inovoject m

“There has been a need for a smaller Inovoject for some time,” she said.

“For smaller hatcheries, or those in developing countries which have traditionally relied on manual labour to vaccinate each bird individually after hatch, the availability of a semi-automated in ovo vaccination system that is the right size for their hatchery, will be a real breakthrough.”

The full-size Inovoject can vaccinate up to 70,000 eggs per hour, while Inovoject m is designed for a throughput of between 12,000 and 20,000 eggs per hour. A more modest device in a compact size means that more hatcheries will be able to switch from manual subcutaneous vaccination and thus improve flock health by protecting birds prior to hatch.

“The Inovoject m has a number of operational advantages for the producer who currently vaccinates chicks on day of hatch,” said Ms Freson.

“Not least is the fact that chicks can be transferred out of the hatchery and into the growout environment sooner.”

For more information, visit the Pfizer Global Poultry stand 4615 at IPE from 24 to 26 January.

IPE News & Information

Visit our full coverage of IPE here where ThePoultrySite team were fully represented.